Improving the Treatment of Acute Lymphoblastic Leukemia

[Image: see text] l-Asparaginase (EC 3.5.1.1) was first used as a component of combination drug therapies to treat acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow, almost 50 years ago. Administering this enzyme to reduce asparagine levels in the blood is a cornerstone of mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Radadiya, Ashish, Zhu, Wen, Coricello, Adriana, Alcaro, Stefano, Richards, Nigel G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497903/
https://www.ncbi.nlm.nih.gov/pubmed/32786406
http://dx.doi.org/10.1021/acs.biochem.0c00354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497903/
https://www.ncbi.nlm.nih.gov/pubmed/32786406
http://dx.doi.org/10.1021/acs.biochem.0c00354

Ejemplares similares